[ad_1]
Medical staff preparing for vaccination with confidence▶ Click here to enlarge the view
The quarantine authorities expressed their position that they would make a decision after sufficiently analyzing the vaccination results of each country on whether or not to expand the vaccination targets against the new coronavirus infection of AstraZeneca (AZ) (Corona 19).
Consequently, it is worth noting whether those over 65 years of age who were excluded from priority vaccination due to the controversy about the effect of vaccination in the elderly will receive this vaccine.
In an online briefing on day 2, Jung Kyung-sil, head of the vaccination management team of the Corona 19 Vaccination Response Advocacy Team, said: “We are constantly collecting relevant evidence” on whether the elderly 65 years or more have received the AstraZeneca vaccine. “After analyzing this and accumulating evidence, it will be decided after receiving expert advice and deliberation from the Specialist Committee on Vaccination.”
Regarding the specific timing of the decision, he said: “We are not reviewing the data by limiting the specific time period,” he said. “I think that if the data like the thesis and the results of clinical trials accumulate enough, we can judge at any time.”
In the first trimester, the government planned to inoculate the AstraZeneca vaccine to all hospitalized, residents and workers in nursing homes and hospitals in the first trimester, but vaccination was withheld for those 65 and older.
This is in accordance with the recommendation of the Ministry of Food and Pharmaceutical Safety to carefully decide on the use of the AstraZeneca vaccine for those over 65 years of age. The Ministry of Food and Drug Safety at the time demonstrated the safety and effectiveness of the AstraZeneca vaccine, but made this decision due to the lack of clinical studies in the elderly.
In this situation, a recent study in the UK has shown that the AstraZeneca vaccine is also effective for the elderly.
The UK Public Health Administration of England (PHE) surveyed people aged 80 and over who received this vaccine once, and found that hospitalization after 3-4 weeks decreased by 80%, and in people age 70 and over, the effect of preventing infection after 4 weeks of vaccination was 60. It was counted as ~ 73%.
France recognized the effectiveness of the vaccine and extended the vaccination age to 74 years, and Germany is known to reconsider its policy of “ not recommending the AstraZeneca vaccine to the elderly. ”
“Clinical trials are currently underway in each country and, in some countries, the results of vaccination for the elderly are being published,” said Mr. Jeong. “Not only the results of the US clinical trial, but also the vaccination results of each country are reported as a whole.) I will decide.”
Currently, starting on the 26th of last month in Korea, among hospitalized patients, residents and workers of nursing homes and nursing homes, those under 65 will receive the AstraZeneca vaccine, and from 27, medical staff and workers of the crown. The patient treatment hospital and life treatment center will be Pfizer. I’m going to get the vaccine.
Insuring half of the people who get vaccinated abroad … Are there any breaks in the vaccination schedule? (CG)▶ Click here to enlarge the view
On the other hand, the government knows who will be vaccinated each month and delivers the required amount of vaccine to each institution, but it is known that it is proceeding without problems. When the monthly vaccination goal is confirmed, the government gives access to the ‘subject registration system’ to the facilities where they are located, and requires each institution to enter the target person.
In this regard, he said, “so far we are proceeding as planned without any delay,” but said, “However, there may be cases where registration of target subjects is partially delayed due to so many institutions.”
“Currently there is no report that the establishment of the center is delayed by this problem.” “We are going to install the center, but now we are paying the rent through the national treasury, so we will be able to cover the cost of installing the center.”
Currently there are 5 vaccination centers for mRNA (messenger ribonucleic acid) vaccines such as Pfizer, a central vaccination center, three regional centers and a regional center.
[연합뉴스]
Copyright ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited
